Ribera 2005.
| Methods | Randomized controlled trial |
| Participants | 54 HAART naive patients |
| Interventions | Stavudine 40mg or 30mg twice a day as part of HAART for 48 weeks |
| Outcomes | Rates of virologic suppression and CD4 cell count increase |
| Notes |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.